Cell Culture Collective, Inc. Announces Partnership with Defined Bioscience, Inc. to Distribute Serum-Free Stem Cell Culture Products
Through this collaboration, Cell Culture Collective will become an authorized distributor for Defined Bioscience's optimized animal/serum-free stem cell culture products. (Source: The Scientist)
Source: The Scientist - September 27, 2023 Category: Science Tags: The Marketplace The Scientist Source Type: news
Stem Cell Treatment Halts MS for Some Patients
WEDNESDAY, Sept. 27, 2023 -- A new study is strengthening the evidence that stem cell transplants can be highly effective for some people with multiple sclerosis -- sending the disease into remission for years, and sometimes reversing... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 27, 2023 Category: General Medicine Source Type: news
FDA Review Skeptical of ALS Stem Cell Therapy FDA Review Skeptical of ALS Stem Cell Therapy
The FDA has raised concerns about the safety and efficacy of an experimental stem cell therapy for ALS scheduled for a public hearing by a federal advisory panel on Wednesday.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - September 27, 2023 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news
aHSCT Beneficial for Most Patients With Relapsing-Remitting MS
TUESDAY, Sept. 26, 2023 -- Autologous hematopoietic stem cell transplantation (aHSCT) for treatment of relapsing-remitting multiple sclerosis (RRMS) yields freedom from disease activity for most patients, according to a study published online Sept.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 26, 2023 Category: Pharmaceuticals Source Type: news
FDA Skeptical of Experimental ALS Treatment Pushed by Patient Advocates
In documents posted Monday, the FDA reiterated its longstanding position that drugmaker Brainstorm's lone study doesn't provide convincing evidence that its stem cell-based therapy helps patients with ALS, or amyotrophic lateral sclerosis. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - September 25, 2023 Category: American Health Source Type: news
Unlocking the Secrets within Cells Using Next Generation Sequencing
Next generation sequencing (NGS) core facility scientists and researchers discuss their latest work exploring novel cancer models and stem cells in space. (Source: The Scientist)
Source: The Scientist - September 25, 2023 Category: Science Tags: Sponsored Webinars Source Type: news
Building in zero gravity: the race to create factories in space
Tech companies see big benefits in making drugs, harvesting stem cells and growing crystals in ‘off-Earth’ conditionsSo far, the public faces of the new space race have been billionaires like Jeff Bezos and Richard Branson joyriding around in rockets, having maybe the most expensive midlife crises ever. But behind the scenes, big tech is thinking more seriously about the first non-Earth production lines.For some startups, the most pressing questions in manufacturing right now are: how do you build computer parts, harvest stem cells or produce pharmaceuticals while in space?Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 25, 2023 Category: Science Authors: Alaina Demopoulos Tags: Space US news Science Technology Source Type: news
Girl receives UK ’s first kidney transplant without need for lifelong drugs
Aditi Shankar, eight, has pioneering treatment resulting in her body accepting donor kidney as its ownAn eight-year-old girl has been spared from taking lifelong drugs to stop her body rejecting her kidney transplant thanks to a UK-first treatment.Aditi Shankar ’s immune system was “reprogrammed” after a stem cell transplant, resulting in her body accepting a donor kidney as its own, clinicians said.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 22, 2023 Category: Science Authors: PA Media Tags: NHS Health UK news Society Source Type: news
Girl, 8, gets kidney transplant without need for life-long drugs in UK-first
The stem cell transplant performed at London's Great Ormond Street (Gosh), means the eight-year-old's body accepted the organ as her own, sparing her a lifetime of medication. (Source: the Mail online | Health)
Source: the Mail online | Health - September 21, 2023 Category: Consumer Health News Source Type: news
Mother of blood cancer survivor in drive for stem cell donors in England
Sarah Cripps launches Swab to Save a Child campaign to encourage more people to register to donateA campaign to get more people to donate stem cells is taking place across England this weekend, as charities say there is an urgent need to increase the register in the UK.A network of mothers have teamed up with the blood cancer charity DKMS to raise awareness and encourage more people to register to donate their stem cells at drive-in events on 17 September.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 14, 2023 Category: Science Authors: Mabel Banfield-Nwachi Tags: Stem cells Cancer England Health Society UK news Source Type: news
Knighted in 2008, Sir Ian Wilmut revolutionized the field of cloning, stem cell research, and regenerative medicine.
(Source: The Scientist)
Source: The Scientist - September 12, 2023 Category: Science Tags: News News & Opinion Source Type: news
FDA OKs Motixafortide for Stem Cell Mobilization in Myeloma FDA OKs Motixafortide for Stem Cell Mobilization in Myeloma
The GENESIS trial reported substantially better stem cell mobilization when patients with multiple myeloma received motixafortide alongside filgrastim.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 11, 2023 Category: Transplant Surgery Tags: Hematology-Oncology News Alert Source Type: news
FDA Approves Aphexda (motixafortide) to Mobilize Hematopoietic Stem Cells for Autologous Transplantation in Patients with Multiple Myeloma
Aphexda is the first innovation in stem cell mobilization for multiple myeloma to be approved in the U.S. in a decade
One dosage of Aphexda plus filgrastim enabled a majority of patients to achieve the collection goal of≥ 6 million... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 11, 2023 Category: Drugs & Pharmacology Source Type: news
Stem-Cell Mobilization Booster Wins FDA Approval for Multiple Myeloma
(MedPage Today) -- The FDA has approved the CXCR4 antagonist motixafortide (Aphexda) for use with filgrastim (Neupogen) to mobilize stem cells for autologous transplantation in multiple myeloma, BioLineRx announced on Monday.
Recent advances in... (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - September 11, 2023 Category: Surgery Source Type: news
FLT3 Inhibitor Improves AML Survival With or Without Stem-Cell Transplant
(MedPage Today) -- HOUSTON -- Post-transplant maintenance with an FLT3 inhibitor significantly improved overall survival (OS) in FLT3-positive acute myeloid leukemia (AML), according to a subgroup analysis of a randomized trial.
Patients who... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 11, 2023 Category: Hematology Source Type: news
